Corporate Profile

Origin

The “TUNZ” in TUNZ Pharma combines the initials of Tokai University,
which will create the seeds of innovative technologies,
and Nippon Zoki as the university’s development partner.

Members

Daisuke Sakai

Doctor of Medicine (MD)
Scientific Advisor Daisuke Sakai

Associate Professor, Department of Orthopaedic Surgery, Faculty of Medicine, Tokai University School of Medicine

Consolidating knowhow from medical practice to discover new drugs

As a spine surgeon who treats back pain and other conditions, I was often frustrated by the lack of real solutions. The possibility of finding effective treatments has prompted me to continue research into regenerative medicine. I grew up in America, and I think that the emphasis which the American education system puts on practical thinking has certainly been behind some of my research achievements.
With Japanese medical research starting to fall behind internationally, TUNZ Pharma’s raison d’être definitely lies in engaging in regenerative medicine research and developing real solutions such as drugs and biomaterials that respond to the needs of medical practitioners and, above all, the needs of patients.

Profile
March 1999Graduated from the Faculty of Medicine within the Tokai University School of Medicine
March 2005Completed a doctoral degree in medicine at the Tokai University Graduate School of Medicine
April 2007Became a lecturer in the Department of Orthopaedic Surgery (Faculty of Medicine) at the Tokai University School of Medicine
April 2012Took up his current position, specializing in spine and spinal cord disorders
2012His finding that stem cell exhaustion is one cause of intervertebral disc aging and degeneration was published in Nature Communications
April 2013Studied abroad at the University of California, San Diego and the Rady Children's Hospital
April 2014Returned to his position as associate professor in the Department of Orthopaedic Surgery (Faculty of Medicine) at the Tokai University School of Medicine
Takafumi Konishi

Takafumi Konishi CEO
TUNZ Pharma Co., Ltd.

Profile
April 2011Joined a domestically-funded pharmaceutical manufacturer specializing in dermatology
April 2013Joined Nippon Zoki Pharmaceutical Co., Ltd.
March 2016Completed the University of Tokyo’s 12th Executive Management Program
Mitsuru Naiki

Mitsuru Naiki Director
TUNZ Pharma Co., Ltd.

Profile
April 1980Joined Nippon Zoki Pharmaceutical Co., Ltd.
Doctor of Pharmacology; pharmacist

Message

As a pharmaceutical company dedicated to developing and manufacturing original drugs focused on patient needs and based on the fundamental ideals of creativity and safety, we at Nippon Zoki will continue to use our research capacity to evolve our innovative products one step at a time, constantly aspiring to our goal of ridding the world of intractable disease.

Ryusaku Konishi CEO/President
Nippon Zoki Pharmaceutical Co., Ltd.

Ryusaku Konishi

Overview